With Patent in Hand and an Encouraging Analyst Report, Amazon Biotech Is Moving Forward With Its Phase I/II Clinical Trial Preparations
NEW YORK, NY -- (MARKET WIRE) -- February 26, 2007 -- Amazon Biotech, Inc. (OTCBB: AMZB) (FRANKFURT: B2D) has been issued a patent from the United States Patent and Trademark Office, patent # 7,160,561 for "a herbal composition and method of treating HIV infection."